Basis: FMP quote market capitalization / revenue from four consecutive issuer fiscal quarters. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the P/S ratio high or low?
The P/S ratio of 88.83 is 82% below its estimated 1-year average of 500.86, near the low end of its estimated 1-year range (88.83–963.93).
As of 2026-10-06T20:13:42.052Z.
Calculation as of: 2026-10-06T20:13:42.052Z.
Quote observation: 2026-10-06T20:00:01.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 5b78614721c2e7423c3fee294265919eb0ef2e62d2038ec7ce10feded39bb20b
Current P/S: FMP quote market capitalization / TTM revenue. Historical estimates use price and reported weighted-average shares; daily points use adjusted close × quarterly weighted-average shares / TTM revenue. Historical series through 2026-10-05.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
PS RATIO
88.83
PS RATIO AVG TTM
N/A
PS RATIO AVG 3Y
N/A
PS RATIO AVG 5Y
N/A
PS RATIO AVG 10Y
N/A
PS RATIO AVG 15Y
N/A
PS RATIO AVG 20Y
N/A
CURRENT VS TTM AVG
N/A
CURRENT VS 3Y AVG
N/A
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
4.27
median of 579 covered companies
CURRENT VS SECTOR MEDIAN
+1980.33%
vs the sector median at left
Market Cap
$115.67M
PS Ratio
3.15
TTM Avg
11.54
3Y Avg
10.77
5Y Avg
81.00
| NAME | MARKET CAP | PS RATIO | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Tenaya Therapeutics, Inc. (TNYA) | $118.59M | 88.83 | N/A | N/A | N/A |
| LENZ Therapeutics, Inc. (LENZ)vs › | $118.83M | 5.53 | 34.83 | 63.67 | 63.67 |
| Spruce Biosciences, Inc. (SPRB)vs › | $117.76M | N/A | 28.59 | 17.79 | 17.79 |
| Cibus, Inc. (CBUS)vs › | $119.84M | 27.57 | 25.82 | 87.76 | 78.89 |
| Seer, Inc. (SEER)vs › | $120.41M | 8.69 | 7.14 | 7.75 | 61.78 |
| MaxCyte, Inc. (MXCT)vs › | $116.76M | 3.76 | 3.79 | 7.32 | 10.74 |
| enGene Holdings Inc. (ENGN)vs › | $120.58M | N/A | N/A | N/A | N/A |
| Foghorn Therapeutics Inc. (FHTX)vs › | $115.67M | 3.15 | 11.54 | 10.77 | 81.00 |
| BGM Group Ltd. (BGM)vs › | $121.55M | N/A | N/A | N/A | N/A |
| Tonix Pharmaceuticals Holding Corp. (TNXP)vs › | $122.66M | 4.21 | 11.00 | 311.63 | 311.63 |
Trailing-12-month revenue adds these four fiscal quarters. Amounts are in USD, rounded only to whole currency units.
| Fiscal period | Revenue | Source |
|---|---|---|
| Q3 FY2025Period ended 2025-09-30 | $0 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2025-11-10 |
| Q4 FY2025Period ended 2025-12-31 | $0 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-03-11 |
| Q1 FY2026Period ended 2026-03-31 | $225,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-05-06 |
| Q2 FY2026Period ended 2026-06-30 | $1,110,000 | Filing link unavailableFMP normalized income statementFiling date supplied by FMP: 2026-08-05 |
| TTM revenue | $1,335,000 |
Current P/S: $118,589,954 market capitalization ÷ $1,335,000 TTM revenue = 88.83x.
Market capitalization source: FMP quote. Quote observed 2026-10-06T20:00:01.000Z. Latest revenue period ended 2026-06-30.
Current market capitalization comes from the quote provider. EPS weighted-average shares are a separate measure.
At 88.83, P/S is at an extreme level, where the multiple carries little signal — higher than 0% of readings in its estimated 1-year history.
Historical values estimate market capitalization from statement-period weighted shares. Comparisons with the current quote-based value are approximate. Only filing versions delivered by FMP are available for the historical calculation.
estimated 1-year low
91.94
median
693.30
estimated 1-year high
963.93
P/S Ratio
88.83
Market Cap / Trailing Twelve-Month Revenue
PS Ratio = Market Cap / Revenue (TTM)
The price-to-sales ratio compares market capitalization to trailing revenue. It is useful for valuing companies with little or no earnings.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | PS RATIO |
|---|---|
| 2026-10-05 | 91.94 |
| 2026-10-02 | 91.94 |
| 2026-10-01 | 92.20 |
| 2026-09-30 | 98.37 |
| 2026-09-29 | 96.66 |
| 2026-09-28 | 96.12 |
| 2026-09-25 | 99.35 |
| 2026-09-24 | 101.05 |
| 2026-09-23 | 107.78 |
| 2026-09-22 | 111.18 |
| 2026-09-21 | 109.81 |
| 2026-09-18 | 110.71 |
| 2026-09-17 | 109.55 |
| 2026-09-16 | 107.19 |
| 2026-09-15 | 109.28 |
| 2026-09-14 | 112.93 |
| 2026-09-11 | 104.31 |
| 2026-09-10 | 105.74 |
| 2026-09-09 | 107.73 |
| 2026-09-08 | 108.12 |
| 2026-09-04 | 111.35 |
| 2026-09-03 | 113.32 |
| 2026-09-02 | 113.97 |
| 2026-09-01 | 111.70 |
| 2026-08-31 | 112.10 |
| 2026-08-28 | 112.47 |
| 2026-08-27 | 113.30 |
| 2026-08-26 | 113.46 |
| 2026-08-25 | 114.31 |
| 2026-08-24 | 109.96 |
| 2026-08-21 | 113.64 |
| 2026-08-20 | 112.54 |
| 2026-08-19 | 116.19 |
| 2026-08-18 | 113.84 |
| 2026-08-17 | 114.10 |
| 2026-08-14 | 118.66 |
| 2026-08-13 | 119.46 |
| 2026-08-12 | 124.43 |
| 2026-08-11 | 122.44 |
| 2026-08-10 | 120.18 |
| 2026-08-07 | 118.45 |
| 2026-08-06 | 118.29 |
| 2026-08-05 | 756.39 |
| 2026-08-04 | 714.85 |
| 2026-08-03 | 702.70 |
| 2026-07-31 | 713.59 |
| 2026-07-30 | 722.94 |
| 2026-07-29 | 708.58 |
| 2026-07-28 | 728.82 |
| 2026-07-27 | 741.84 |
| 2026-07-24 | 747.04 |
| 2026-07-23 | 745.21 |
| 2026-07-22 | 760.54 |
| 2026-07-21 | 794.85 |
| 2026-07-20 | 788.68 |
| 2026-07-17 | 787.53 |
| 2026-07-16 | 807.38 |
| 2026-07-15 | 812.78 |
| 2026-07-14 | 833.41 |
| 2026-07-13 | 806.32 |
| 2026-07-10 | 839.00 |
| 2026-07-09 | 819.34 |
| 2026-07-08 | 848.16 |
| 2026-07-07 | 886.81 |
| 2026-07-06 | 834.18 |
| 2026-07-02 | 758.51 |
| 2026-07-01 | 718.99 |
| 2026-06-30 | 712.44 |
| 2026-06-29 | 708.39 |
| 2026-06-26 | 691.62 |
| 2026-06-25 | 684.39 |
| 2026-06-24 | 704.53 |
| 2026-06-23 | 699.81 |
| 2026-06-22 | 674.75 |
| 2026-06-18 | 704.24 |
| 2026-06-17 | 685.83 |
| 2026-06-16 | 655.47 |
| 2026-06-15 | 692.77 |
| 2026-06-12 | 686.12 |
| 2026-06-11 | 693.83 |
| 2026-06-10 | 673.11 |
| 2026-06-09 | 684.39 |
| 2026-06-08 | 661.64 |
| 2026-06-05 | 701.83 |
| 2026-06-04 | 744.25 |
| 2026-06-03 | 757.45 |
| 2026-06-02 | 761.50 |
| 2026-06-01 | 838.61 |
| 2026-05-29 | 837.65 |
| 2026-05-28 | 770.08 |
| 2026-05-27 | 763.53 |
| 2026-05-26 | 753.79 |
| 2026-05-22 | 744.63 |
| 2026-05-21 | 761.50 |
| 2026-05-20 | 778.95 |
| 2026-05-19 | 759.09 |
| 2026-05-18 | 754.75 |
| 2026-05-15 | 826.37 |
| 2026-05-14 | 901.27 |
| 2026-05-13 | 924.89 |
| 2026-05-12 | 963.93 |
| 2026-05-11 | 962.09 |
| 2026-05-08 | 963.93 |
| 2026-05-07 | 817.79 |
These references are supplied through FMP. Full filing context identifiers and dimensional metadata are unavailable in the normalized feed.